300086 康芝药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-8.824-17.4030.867-13.3030.731
总资产报酬率 ROA (%)-5.013-10.4410.518-7.9030.433
投入资产回报率 ROIC (%)-5.826-11.9500.588-8.9460.498

边际利润分析
销售毛利率 (%)53.36455.35660.00750.79650.457
营业利润率 (%)-34.287-47.0263.378-39.8342.557
息税前利润/营业总收入 (%)-30.067-44.7216.218-36.6934.600
净利润/营业总收入 (%)-30.064-47.4660.699-36.9491.264

收益指标分析
经营活动净收益/利润总额(%)114.83173.428146.64169.002-30.263
价值变动净收益/利润总额(%)0.0000.625-49.4788.689290.212
营业外收支净额/利润总额(%)-0.0614.149-6.5583.661-5.075

偿债能力分析
流动比率 (X)0.6730.8941.6011.3291.485
速动比率 (X)0.3110.5160.9800.9911.077
资产负债率 (%)42.85741.02236.36840.76836.813
带息债务/全部投入资本 (%)27.00527.94024.55030.93126.955
股东权益/带息债务 (%)244.591236.186289.663209.659257.840
股东权益/负债合计 (%)130.369140.639170.741141.076166.157
利息保障倍数 (X)-7.161-10.3032.040-7.8832.123

营运能力分析
应收账款周转天数 (天)47.70877.78450.38274.09263.488
存货周转天数 (天)314.162361.355247.588251.465177.116